MedTrace Logo

Assessing Impact of Myofascial Release Versus Dry Needling for Chondromalacia in Adult Females

NCT06980883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-05-20

No results posted yet for this study

Summary

Assessing Impact of Myofascial Release versus Dry Needling for Chondromalacia in Adult females. The study employed a Randomized Controlled Trial (RCT) design.

Conditions

  • Chondromalacia

Interventions

OTHER

Dry Needling

dry needles Administered to patients in Group 1 as part of their treatment regimen( 2 days per week).

OTHER

myofascial release

Myofascial Release: Provided to patients in Group 2 along with traditional treatment( 2 days per week). Evaluation of fascial restriction was assessed using the therapists elbow. Any restrictions felt were assessed and given treatment.Myofascial chain release- Position of the patient- Supine lying, prone lying and side lying Position of the therapist- Side of the patient limb to be treated \- Technique-Using the therapist elbow a vertical release proximal to the attachment of the muscle belly or fascia was applied. Once an end-feel was reached a slow stroke down the length of the target tissue was performed along with monitoring the indirect feedback and tissue tension to identify any additional restrictions. The long stroke was repeated in a line parallel to the first stroke. It was continued until an end-feel is reached throughout the entire muscle belly or fascia on the most restricted/ painful points.

OTHER

(traditional exercises)

comprising straight leg raising and isometric quadriceps exercises (2 days per week).

Sponsors & Collaborators

  • Badr University

    lead OTHER

Principal Investigators

  • Doaa S Mohamed, lecturer · lecturer physical therapy for women health Badr University at Cairo

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-05-01
Completion
2025-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06980883 on ClinicalTrials.gov